Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value chain analysis
6. Porter’s 5 forces model
7. PEST analysis
8. Global L-carnitine Market segmentation, By Process:
8.1 Chemical Synthesis
8.2 Bioprocess
9. Global L-carnitine Market segmentation, By Product:
9.1 Food & Pharma Grade
9.2 Feed Grade
10. Global L-carnitine Market segmentation, By Application:
10.1 Animal Feed
10.2 Healthcare Products
10.3 Functional Food & Beverages
10.4 Medicines
11. Global Industrial Starch Market, by region/ country
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company profiles
12.1 Lonza
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 Swot Analysis
12.1.4 The SNS View
12.2 Northeast Pharmaceutical Group Co., Ltd. (NEPG)
12.3 Biosint S.p.A.
12.4 Cayman Chemical
12.5 Merck KGaA
12.6 Tokyo Chemical Industry Co., Ltd.
12.7 Ceva
12.8 Kaiyuan Hengtai Nutrition Co., Ltd.
12.9 ChengDa PharmaCeuticals Co., Ltd.
12.10 Huanggang Huayang Pharmaceutical Co. Ltd.
12.11 HuBeiYuancheng SaichuangTechnology Co, Ltd.
13. Competitive Landscape
13.1 Competitive Bench Marking
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
